Laxminarayan Bhat
Fortuna: 78 130 $ al 30/06/2026
Fortuna: 78 130 $ al 30/06/2026
Dr. Laxminarayan Bhat is a President, Chief Executive Officer & Director at Reviva Pharmaceuticals Holdings, Inc. and a President, Chief Executive Officer & Director at Reviva Pharmaceuticals, Inc. He is on the Board of Directors at Reviva Pharmaceuticals Holdings, Inc. and Reviva Pharmaceuticals, Inc. Dr. Bhat was previously employed as a Research Scientist by ARYx Therapeutics, Inc. and a Research Scientist by XenoPort, Inc. He received his doctorate degree from North-Eastern Hill University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
| 25/03/2026 | 124.213 ( 0,97 % ) | 78 130 $ | 30/06/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| REVIVA PHARMACEUTICALS HOLDINGS, INC. | Fundador | 11/12/2020 |
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Fundador | 01/01/2006 |
| Empresas | Cargo | Fin |
|---|---|---|
| ARYX THERAPEUTICS, INC. | Director Técnico/Científico/I+D | 02/01/2006 |
| XENOPORT, INC. | Director Técnico/Científico/I+D | 02/01/2004 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 5 |
|---|---|
Reviva Pharmaceuticals, Inc.
Reviva Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Operates as a clinical-stage pharmaceutical company developing therapies for unmet medical needs in central nervous system, cardiovascular, metabolic and inflammatory diseases | Health Technology |
ARYx Therapeutics, Inc.
ARYx Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Discovers and develops drugs | Health Technology |
XenoPort, Inc.
XenoPort, Inc. Pharmaceuticals: MajorHealth Technology Engages in developing and commercializing of pharmaceutical products for the potential treatment of neurological disorders | Health Technology |
North-Eastern Hill University
North-Eastern Hill University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Reviva Pharmaceuticals Holdings, Inc.
Reviva Pharmaceuticals Holdings, Inc. Pharmaceuticals: MajorHealth Technology Develops therapies for central nervous system, cardio vascular, metabolic and inflammatory diseases | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.